Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
01 03 2022
Historique:
received: 20 06 2021
accepted: 29 11 2021
pubmed: 12 1 2022
medline: 11 3 2022
entrez: 11 1 2022
Statut: ppublish

Résumé

This study aimed to 1) identify the frequency of severe and level 2 hypoglycemia presenting in individuals with type 1 diabetes using continuous glucose monitoring systems (CGMs), including those with concomitant closed-loop insulin pumps, in a clinical practice setting and 2) evaluate the impact of beliefs around hypoglycemia in the development of severe and level 2 hypoglycemia in this population. A cross-sectional survey study in adults with type 1 diabetes using CGMs >6 months was conducted at a large tertiary academic center. Participant demographics, 6-month severe hypoglycemia history, hypoglycemia beliefs (with the Attitude to Awareness of Hypoglycemia questionnaire), and 4-week CGM glucose data were collected. Statistical analysis was performed to assess the presentation of severe and level 2 hypoglycemia and identify associated risk factors. A total of 289 participants were recruited (including 257 participants with CGM data within the last 3 months). Of these, 25.6% experienced at least one severe hypoglycemic episode in the last 6 months, and 13.6% presented with ≥1% of time in level 2 hypoglycemia on CGMs. Reporting beliefs about prioritizing hyperglycemia avoidance was associated with severe hypoglycemia development (P < 0.001), while having beliefs of minimal concerns for hypoglycemia was associated with spending ≥1% of time in level 2 hypoglycemia (P = 0.038). Despite the use of advanced diabetes technologies, severe and level 2 hypoglycemia continues to occur in individuals with type 1 diabetes and high hypoglycemia risks. Human factors, including beliefs around hypoglycemia, may continue to impact the effectiveness of glucose self-management.

Identifiants

pubmed: 35015079
pii: 139256
doi: 10.2337/dc21-1285
pmc: PMC8918194
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0
Insulin 0

Banques de données

figshare
['10.2337/figshare.17136467']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

520-528

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK118082
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092926
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK129724
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States

Informations de copyright

© 2022 by the American Diabetes Association.

Références

SAGE Open Med. 2014 Apr 03;2:2050312114527443
pubmed: 26770717
J Diabetes Investig. 2019 Mar;10(2):219-220
pubmed: 30175462
Diabetes Care. 2018 Dec;41(12):2625-2633
pubmed: 30327358
Diabetes Care. 2015 Apr;38(4):544-50
pubmed: 25552422
Diabet Med. 2021 May;38(5):e14528
pubmed: 33496979
Diabetes Care. 2017 Dec;40(12):1661-1667
pubmed: 28928117
Diabetes Technol Ther. 2019 Feb;21(2):66-72
pubmed: 30657336
Diabetes Care. 1994 Jul;17(7):697-703
pubmed: 7924780
JAMA. 2020 Jun 16;323(23):2397-2406
pubmed: 32543682
Diabetes Technol Ther. 2021 Mar;23(S1):S21-S26
pubmed: 33434439
Diabetes Care. 2020 Oct;43(10):e142-e143
pubmed: 32820010
Diabetes Care. 2019 Oct;42(10):1854-1864
pubmed: 31391200
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Sci Rep. 2020 Oct 23;10(1):18180
pubmed: 33097760
PLoS Med. 2014 Oct 07;11(10):e1001742
pubmed: 25289645
N Engl J Med. 2019 Oct 31;381(18):1707-1717
pubmed: 31618560
BMJ Open. 2019 Jun 16;9(6):e030356
pubmed: 31209097
Diabet Med. 2012 Mar;29(3):321-7
pubmed: 21913969
BMJ. 2010 Jan 08;340:b4909
pubmed: 20061358
Diabetes. 2014 May;63(5):1738-47
pubmed: 24757202
BMJ Open Diabetes Res Care. 2021 Jan;9(1):
pubmed: 33431600
Diabetes Care. 2017 Dec;40(12):1622-1630
pubmed: 29162582
Diabetes Care. 2021 Apr;44(4):969-975
pubmed: 33579715
J Endocr Soc. 2019 Nov 19;4(1):bvz005
pubmed: 31993548
J Diabetes. 2019 Sep;11(9):711-718
pubmed: 30983138
Diabetes Care. 2018 Aug;41(8):1783-1791
pubmed: 29903847
Diabetes Care. 2021 Jan;44(Suppl 1):S73-S84
pubmed: 33298417
Diabetes Care. 2017 Dec;40(12):1641-1643
pubmed: 29162584
J Diabetes Sci Technol. 2019 Jul;13(4):636-644
pubmed: 30841740
Diabetes Ther. 2021 Jan;12(1):441-451
pubmed: 33219468
Diabetologia. 2018 Apr;61(4):761-769
pubmed: 29423581
Diabetes Care. 1999 Mar;22 Suppl 2:B40-2
pubmed: 10097898
Expert Rev Med Devices. 2020 Jul;17(7):707-720
pubmed: 32569476
Diabetes Care. 2021 Jan;44(Suppl 1):S85-S99
pubmed: 33298418
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
N Engl J Med. 2013 Jul 25;369(4):362-72
pubmed: 23883381

Auteurs

Yu Kuei Lin (YK)

Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.

Caroline R Richardson (CR)

Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI.

Iulia Dobrin (I)

Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.

Melissa J DeJonckheere (MJ)

Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI.
Mixed Methods Program, Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI.

Kara Mizokami-Stout (K)

Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.

Michael D Fetters (MD)

Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI.
Mixed Methods Program, Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI.

James E Aikens (JE)

Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI.

Simon J Fisher (SJ)

Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, KY.

Wen Ye (W)

Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI.

Rodica Pop-Busui (R)

Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH